Did You Know...
...During the Civil War, the Confederacy established its own Patent Office which issued 266 patents, a third of which concerned implements of war.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7314638 | Preparing method for controlled released type tablet tamsulosin HCL and the tablet thereof The present invention relates to a simple and effective method for preparing a tamsulosin HCl sustained-release tablet and a tamsulosin HCl sustained-release tablet produced thereby. The method comprises the steps of: dissolving tamsulosin HCl as an active ingredien... | 01/01/2008 |
| 7229642 | Amino acid modulated extended release dosage form Disclosed herein is a oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an intragranular polymer in which the granule is dispersed within a hydrophilic extr... | 06/12/2007 |
| 7144585 | Cilostazol preparation Provided is a cilostazol preparation which comprises incorporating a fine powder of cilostazol into a dispersing and/or solubilizing agent thereby to enhance the dispersibility and/or solubility. Further, provided is a process for improving absorbability of a slight... | 12/05/2006 |
| 7097859 | Indium supplement compositions and methods therefor A tablet for oral administration of nutritional indium comprises about 10–50 mg indium sulfate, about 4–20 mg caffeine, about 2–10% by weight cocoa powder, and about 5–10% by weight ethyl cellulose, in combination with about 50–150 μg of each of zinc oxid... | 08/29/2006 |
| 7090867 | Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum The present invention provides a controlled release device for sustained or pulsatile delivery of pharmaceutically active substances for a predetermined period of time. This invention further provides such device in which sustained or pulsatile delivery is obtained ... | 08/15/2006 |
| 7015177 | Solid formulation A solid formulation of an agrochemical is prepared by forming a melt containing at least one agrochemical and at least one thermoplastic binder having a melting point or glass temperature of greater than 35° C., briquetting the melt by dividing it into drops in a f... | 03/21/2006 |
| 6936275 | Amino acid modulated extended release dosage form Disclosed herein is a oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an intragranular polymer in which the granule is dispersed within a hydrophilic extr... | 08/30/2005 |
| 6914073 | Vitamin formulation for cardiovascular health The invention concerns a composition containing a high level of Vitamin E in encapsulated form, preferably as beadlets or spray dried, and a high level of silicates. The composition is compressible into tablets or caplets that do not leach out Vitamin E into the tab... | 07/05/2005 |
| 6849286 | Method for producing a tablet made of isomaltulose, isomalt or isomalt variants The present invention relates to a method of producing an improved compressed product, wherein agglomeration of the ingredients is induced. This invention also relates to a compressed product produced by this method. ... | 02/01/2005 |
| 6797283 | Gastric retention dosage form having multiple layers The present invention is directed to a multilayered dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent to a fluid environment of use. The active agent dosage form is a multilayer core, often bilayer, fo... | 09/28/2004 |
| 6761905 | Process for the preparation of direct tabletting formulations and aids A thermal adhesion granulation process for preparing direct tabletting formulations or aids is disclosed. The process comprises the step of subjecting all or part of a mixture comprising: A) from about 5 to about 99% by weight of one or more diluent excipient... | 07/13/2004 |
| 6746874 | Reagent preparation containing magnetic particles in tablet form Subject matter of the invention is a reagent preparation for binding components of a sample in the form of a tablet comprising a multitude of magnetic particles which are held together with the aid of excipients, and the use of this reagent preparation in analytical... | 06/08/2004 |
| 6667055 | Filler binder for tablets The invention relates to a novel filler-binder for tablets, which shows a significantly reduced lubricant sensitivity when compared to prior art filler-binders. The invention further relates to a process of making said filler-binder and to the tablet obta... | 12/23/2003 |
| 6607751 | Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum The present invention provides a controlled release device for sustained or pulsatile delivery of pharmaceutically active substances for a predetermined period of time. This invention further provides such device in which sustained or pulsatile delivery i... | 08/19/2003 |
| 6569460 | Film-coated tablet for improved upper gastrointestinal tract safety A novel oral dosage to be delivered to the stomach comprising a safe and effective amount of an active ingredient selected from the group consisting of emepronium bromidebromide, doxycycline, and other tetracyclines/antibiotics, iron preparations, quinidi... | 05/27/2003 |
| 6555581 | Levothyroxine compositions and methods The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ing... | 04/29/2003 |
| 6517868 | Amino acid modulated extended release dosage form Disclosed herein is a tableted oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an intragranular polymer in which the granule is dispersed withi... | 02/11/2003 |
| 6491946 | Pharmaceutical levothyroxine preparation The invention relates to a pharmaceutical preparation comprising levothyroxine sodium, potassium iodide, microcrystalline cellulose and binding agent, which is free of antioxidants or further auxiliaries, and processes for its production.... | 12/10/2002 |
| 6465010 | Means for creating a mass having structural integrity The present invention relates to a means for creating a mass having structural integrity, including a rapidly disintegratable tablet for administration with or without the use of water. The present invention has a wide variety of different uses and applic... | 10/15/2002 |
| 6444218 | Soft chewable multivitamin tablet comprising separated active ingredients The present invention provides an improved soft chewable multivitamin tablet in which vitamin C is separated from calcium pantothenate and/or minerals such as iron, copper, zinc and mixtures thereof in a core or multilaminate form and a process for prepar... | 09/03/2002 |
| 6440450 | Soft chewable tablet comprising separated active ingredients The present invention provides an improved soft chewable multivitamin tablet in which vitamin C is separated from calcium pantothenate and/or minerals such as iron, copper, zinc and mixtures thereof in a core or multilaminate form and a process for prepar... | 08/27/2002 |
| 6423341 | ଲ-lactam antibiotic-containing tablet and production thereof This invention provides ଲ-lactam antibiotic-containing tablets capable of being orally taken either as such owing to their being small-sized, hence still easily swallowable, or, in the case of administration to the aged encountering some difficulty ... | 07/23/2002 |
| 6333057 | Composition and method for topical treatment of androgenic alopecia This invention relates to the topical and oral treatment of hair loss, especially androgenic alopecia, by providing formulations that include anti-androgens, especially extracts of the saw palmetto plant, co-enzyme Q, and acetyl carnitine, and optionally ... | 12/25/2001 |
| 6274386 | Reagent preparation containing magnetic particles in tablet form Subject matter of the invention is a reagent preparation for binding components of a sample in the form of a tablet comprising a multitude of magnetic particles which are held together with the aid of excipients, and the use of this reagent preparation in... | 08/14/2001 |
| 6214381 | Methazolamide composition and method of use A pharmaceutical composition useful for treating ocular conditions, such as glaucoma. In particular, the pharmaceutical composition is a sustained release oral dosage composition for relieving intraocular pressure comprising methazolamide and a high molec... | 04/10/2001 |
| 6171616 | Solid preparation and a method of manufacturing it A solid preparation characteristically containing for a binder methyl cellulose whose MeO content is 27.5-31.5 wt % and whose 2 wt % aqueous solution has a viscosity of 2-12 cP at 20° C. The present invention can provide a solid preparation which has an adequ... | 01/09/2001 |
| 6165513 | Film-coated tablet for improved upper gastrointestinal tract safety A novel oral dosage to be delivered to the stomach comprising a safe and effective amount of an active ingredient selected from the group consisting of emepronium bromidebromide, doxycycline, and other tetracyclines/antibiotics, iron preparations, quinidi... | 12/26/2000 |
| 6117453 | Solid compositions containing polyethylene oxide and an active ingredient A solid composition is disclosed comprising an active ingredient that is not in amorphous form in association with polyethylene oxide and conventional additives, excluding basic compounds. Such compositions are suitable for use as pharmaceutical compositi... | 09/12/2000 |
| 6093387 | Extended-release chemical formulation in tablet form for urine pretreatment The present invention provides water-soluble, extended-release chemical formulations, in tablet form, for urine pretreatment, that require minimal, if any, use of a binder component, yet are non-dusting, pliable, structurally strong, and not weakened by e... | 07/25/2000 |
| 6083532 | Sustained release formulation containing three different types of polymers and tablet formed therefrom Depot drug formulations include the pharmaceutical itself and a three component release rate controlling matrix composition. The three components of the matrix composition are (1) a pH dependent gelling polymer such as an alginate component, (2) an enteri... | 07/04/2000 |
| 6066335 | Method of producing effervescent tablets and effervescent tablet A method of producing mechanically stable effervescent tablets with a high dissolving velocity and an according effervescent tablet are described. The effervescent tablets consist of at least one active substance or of a combination of active substances, ... | 05/23/2000 |
| 5989589 | Cross-linked cellulose as a tablet excipient Cross-linked cellulose is an excellent binder disintegrant that can be used in the preparation of pharmaceutical tablets. The tablets that are so prepared are made of a compressed mixture of a powder of a pharmaceutically active ingredient with a powder o... | 11/23/1999 |
| 5876707 | Extended-release chemical formulation in tablet form for urine pretreatment The present invention provides water-soluble, extended-release chemical formulations, in tablet form, for urine pretreatment, that require minimal, if any, use of a binder component, yet are non-dusting, pliable, structurally strong, and not weakened by e... | 03/02/1999 |
| 5853758 | Preparation of tablets of increased strength Tablets of increased strength are manufactured by combining and compressing a meltable binder, excipients and a pharmaceutically active agent into a tablet, melting the binder in the tablet, and then solidifying the binder.... | 12/29/1998 |
| 5851579 | Aqueous enteric coating compositions The present invention sets forth an enteric coating composition comprising a blend of a) an alkali-soluble acrylic latex polymer and b) an aqueous solution of ammonium or alkaline salts of cellulose polymers. The invention also sets forth a method for preparing an ... | 12/22/1998 |
| 5811388 | Delivery of drugs to the lower GI tract Pharmaceutical compositions for orally delivering a therapeutically effective amount of a drug to the colon without significant release of the drug in the upper GI tract after oral administration of the composition are described. The composition is a unit... | 09/22/1998 |
| 5753255 | Chewable molded tablet containing medicinally active substances There is provided a chewable medicinal tableting composition comprising as proportions of the total composition which will further comprise the medicinally active component, as first essential component: capric triglyceride: about 30 to about 95% by weigh... | 05/19/1998 |
| 5695781 | Sustained release formulation containing three different types of polymers Verapamil depot drug formulations include the pharmaceutical itself and a three component release rate controlling matrix composition. The three components of the matrix composition are (1) an alginate component, such as sodium alginate, (2) an enteric po... | 12/09/1997 |
| 5660821 | Extended-release chemical formulation in tablet form for urine pretreatment The present invention provides water-soluble, extended-release chemical formulations, in tablet form, for urine pretreatment, that require minimal, if any, use of a binder component, yet are non-dusting, pliable, structurally strong, and not weakened by e... | 08/26/1997 |
| 5626878 | Reduction of electrostatic forces between magnesium trisilicate adsorbates A medicament adsorbate containing corn syrup having contained therein from about 10 to about 90% by weight of the adsorbate of a medicament drug a magnesium trisilicate having a surface area of at least 400 m2 /g and having a structure with mul... | 05/06/1997 |
